SCHEMBL276748

SCHEMBL276748

CCCN1/C(=C/C=C2\CCCC(/C=C/C3=[N+](CCSOOO)c4ccc5ccccc5c4C3(C)C)=C2Cl)C(C)(C)c2c1ccc1ccccc21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT1 Q99873 9/20 0.51
PRMT5 O14744 1/20 0.46
PRMT8 Q9NR22 1/20 0.46
BLM P54132 2/20 0.44
MLNR O43193 1/20 0.43
NR1I2 O75469 1/20 0.43
PGR P06401 1/20 0.43
ADRB1 P08588 1/20 0.43
ADORA3 P0DMS8 1/20 0.43
CHRM1 P11229 1/20 0.43
DRD2 P14416 1/20 0.43
ADRA2B P18089 1/20 0.43
ADRA2C P18825 1/20 0.43
CHRM3 P20309 1/20 0.43
CNR1 P21554 1/20 0.43
DRD1 P21728 1/20 0.43
TBXA2R P21731 1/20 0.43
SLC6A2 P23975 1/20 0.43
HRH2 P25021 1/20 0.43
HTR2C P28335 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14199192 0.92 MLNR (0.51) PRMT1PRMT5PRMT8BLMMLNR
SCHEMBL10065840 0.90 PRMT1 (0.59) PRMT1PRMT5PRMT8BLMMLNR
SCHEMBL13896297 0.86 MLNR (0.55) PRMT1PRMT5PRMT8BLMMLNR
SCHEMBL13452450 0.86 PRMT1 (0.56) PRMT1PRMT5PRMT8BLMMLNR
SCHEMBL5179900 0.85 PRMT1 (0.70) PRMT1PRMT5PRMT8BLMMLNR
SCHEMBL2739556 0.85 PRMT1 (0.70) PRMT1PRMT5PRMT8BLMMLNR
SCHEMBL13813704 0.85 PRMT1 (0.70) PRMT1PRMT5PRMT8BLMMLNR
SCHEMBL5179902 0.85 PRMT1 (0.70) PRMT1PRMT5PRMT8BLMMLNR
SCHEMBL14271330 0.85 PRMT1 (0.65) PRMT1PRMT5PRMT8BLMMLNR
SCHEMBL761512 0.84 PRMT1 (0.54) PRMT1PRMT5PRMT8BLMMLNR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8216769-B2 Negative working, heat sensitive lithographic printing plate precursor AGFA GRAPHICS NV (BE) 2012-07-10 US disclosed
US-8178282-B2 Heat-sensitive imaging element AGFA GRAPHICS NV (BE) 2012-05-15 US disclosed
US-8133657-B2 Method for making a lithographic printing plate AGFA GRAPHICS NV (BE) 2012-03-13 US disclosed
US-20100040976-A1 HEAT-SENSITIVE IMAGING ELEMENT AGFA GRAPHICS NV (BE) 2010-02-18 US disclosed
US-20090258314-A1 NEGATIVE WORKING, HEAT SENSITIVE LITHOGRAPHIC PRINTING PLATE PRECURSOR AGFA GRAPHICS NV (BE) 2009-10-15 US disclosed
US-20090155722-A1 METHOD FOR MAKING A LITHOGRAPHIC PRINTING PLATE AGFA GRAPHICS NV (BE) 2009-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100040976-A1 HEAT-SENSITIVE IMAGING ELEMENT HEATR1, HEATR6, HSPA8 PRMT1 4821/4885PRMT5 4771/4885PRMT8 4581/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.